text stringlengths 15 247 |
|---|
Prostate, biopsy;
No tumor present |
Urinary bladder, transurethral resection;
Invasive urothelial carcinoma,
with involvement of muscle proper
Note) The specimen includes muscle proper. |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 5% |
Prostate, biopsy;
No tumor present |
Urinary bladder, transurethral resection;
Non-invasive papillary urothelial carcinoma, high grade
Note) The specimen includes muscle proper. |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 40% |
Lung, biopsy;
Adenocarcinoma |
Urinary bladder, transurethral resection;
1. No tumor present
2. Chronic granulomatous inflammation with foreign body reaction
Note) The specimen does not include muscle proper. |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 9 (5+4), grade group 5, tumor volume: 80% |
Lung, biopsy;
Adenocarcinoma |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 10% |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (3+4), grade group 2 (Gleason pattern 4: 20%), tumor volume: 60% |
Prostate, biopsy;
No tumor present |
Lung, biopsy;
Non-small cell carcinoma, favor adenocarcinoma |
Lung, biopsy;
Adenocarcinoma |
Stomach, endoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (4+3), grade group 3 (Gleason pattern 4: 70%), tumor volume: 30% |
Urinary bladder, transurethral resection;
Invasive urothelial carcinoma,
with involvement of subepithelial connective tissue
Note) The specimen includes muscle proper. |
Stomach, endoscopic biopsy;
Adenocarcinoma, poorly differentiated with poorly cohesive carcinoma component |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (3+4), grade group 2 (Gleason pattern 4: 20%), tumor volume: 70% |
Lung, biopsy;
Non-small cell carcinoma, favor adenocarcinoma |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 30% |
Urinary bladder, transurethral resection;
Non-invasive papillary urothelial carcinoma, low grade
Note) The specimen includes muscle proper. |
Prostate, biopsy;
No tumor present |
Urinary bladder, transurethral resection;
Invasive urothelial carcinoma,
with involvement of subepithelial connective tissue
Note) The specimen includes muscle proper. |
Urinary bladder, transurethral resection;
Non-invasive papillary urothelial carcinoma, low grade
Note) The specimen includes muscle proper. |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 10% |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (4+3), grade group 3 (Gleason pattern 4: 40%), tumor volume: 80% |
Urinary bladder, transurethral resection;
Urothelial carcinoma in situ
Note) The specimen includes muscle proper. |
Urinary bladder, transurethral resection;
Invasive urothelial carcinoma, with
1) involvement of muscle proper
2) squamous differentiation
Note) The specimen includes muscle proper. |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (4+3), grade group 3 (Gleason pattern 4: 80%), tumor volume: 90% |
Lung, biopsy;
Adenocarcinoma |
Lung, biopsy;
Non-small cell carcinoma, favor squamous cell carcinoma |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (3+4), grade group 2 (Gleason pattern 4: 10%), tumor volume: 40% |
Urinary bladder, transurethral resection;
Urothelial carcinoma in situ
Note) The specimen includes muscle proper. |
Urinary bladder, transurethral resection;
1. Non-invasive papillary urothelial carcinoma, high grade
2. Urothelial carcinoma in situ
Note) The specimen includes muscle proper. |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 5% |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (4+3), grade group 3 (Gleason pattern 4: 90%), tumor volume: 60% |
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 40% |
Rectum, colonoscopic biopsy;
Adenocarcinoma, poorly differentiated |
Uterine cervix, colposcopic biopsy;
Chronic nonspecific cervicitis |
Uterine cervix, punch biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 2) |
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1) |
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 2) |
Lung, biopsy;
Adenocarcinoma |
Lung, biopsy;
Squamous cell carcinoma |
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1) |
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Rectum, colonoscopic mucosal resection;
Tubular adenoma with high grade dysplasia |
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
with glandular involvement |
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1) |
Colon, colonoscopic biopsy;
Adenocarcinoma, poorly differentiated |
Uterine cervix, colposcopic biopsy;
Invasive squamous cell carcinoma |
Colon, colonoscopic biopsy;
Tubular adenoma with high grade dysplasia |
Uterine cervix, punch biopsy;
Invasive squamous cell carcinoma |
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Lung, biopsy;
Squamous cell carcinoma |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 30% |
Colon, colonoscopic submucosal dissection;
Tubular adenoma with high grade dysplasia |
Rectum, colonoscopic biopsy;
Chronic nonspecific inflammation |
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Lung, biopsy;
Squamous cell carcinoma |
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1) |
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1) |
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3) |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 9 (4+5), grade group 5, tumor volume: 20% |
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 100% |
Uterine cervix, punch biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1) |
Lung, biopsy;
Non-small cell carcinoma, not otherwise specified |
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Uterine cervix, colposcopic biopsy;
Chronic nonspecific cervicitis |
Rectum, colonoscopic biopsy;
Tubular adenoma with high grade dysplasia |
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1) |
Colon, colonoscopic biopsy;
Chronic nonspecific inflammation |
Rectum, colonoscopic biopsy;
Adenocarcinoma, well differentiated |
Uterine cervix, punch biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1) |
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 2) |
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 2) |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 5% |
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3) |
Uterine cervix, polypectomy biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3) |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 100% |
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Uterine cervix, colposcopic biopsy;
Endocervical adenocarcinoma, HPV-associated, usual type |
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Rectum, colonoscopic biopsy;
Adenocarcinoma, well differentiated |
Lung, biopsy;
Small cell carcinoma |
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
with glandular involvement |
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 60% |
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3) |
Lung, biopsy;
No evidence of malignancy or granuloma |
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Colon, colonoscopic biopsy;
Chronic active colitis |
Lung, biopsy;
Adenocarcinoma |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.